References
- Jonkman J HG, Upton R A. Pharmacokinetic drug interactions with theophylline. Clin Pharmacokinet 1984; 9: 309–334
- Boucekkine T, Meknini B, Bitoun A, et al. Treatment of duodenal ulcer with rioprostil: a randomized multicentre double-blind study. Scand J Gastroenterol 1989; 24(suppl 164)191–193
- Ouinton A, Goldfain D, Weber F, et al. Treatment of benign gastric ulcer: a comparative clinical trial of rioprostil and ranitidine. Scand J Gastroenterol 1989; 24(suppl 164)178–183
- Rohr W J, Jr, Henderson W M, Shelver W H. In vitro adsorption of theophylline by antacids. Am J Hosp Pharm Sci 1981; 38: 1779–1780
- Shargel L, Stevens J A, Fuchs J E, Yu A BC. Effect of antacid on bioavailability of theophylline from rapid and time-release drug products. J Pharm Sci 1981; 70: 599–602
- Myhre K I, Walstad R A. The influence of antacid on the absorption of two different sustained-release formulations of theophylline. Br J Clin Pharmacol 1983; 15: 683–687
- Powell J R, Rodgers J F, Wargin W A, Cross R E, Eshelman F N. The influence of cimetidine vs ranitidine on theophylline pharmacokinetics. Clin Pharmacol Ther 1982; 31: 261
- Breen K J, Bury R, Desmond P V, et al. Effects of cimetidine and ranitidine on hepatic drug metabolism. Clin Pharmacol Ther 1982; 31: 297–300